4.7 Article

Association between plasma S-adenosy methionine and risk of mortality in patients with coronary artery disease: A cohort study

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 114, 期 4, 页码 1360-1370

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ajcn/nqab210

关键词

S-adenosylmethionine; S-adenosylhomocysteine; homocysteine; coronary artery disease; cardiovascular; mortality

资金

  1. National Natural Science Foundation of China [82073530, 81730090, 81402672]
  2. Guangdong Provincial Medical Research Fund [A2019017]
  3. Shenzhen Science and Technology Plan Project [JCYJ20190809144001733]
  4. China Postdoctoral Fund [2017M612624]
  5. Guangdong Provincial Key Laboratory of Digestive Cancer Research [2021B1212040006]

向作者/读者索取更多资源

The study found a significant inverse relationship between plasma SAM concentration and the risk of all-cause and cardiovascular mortality in patients with coronary artery disease, with lower SAM concentration associated with higher mortality risk.
Background: S-adenosylmethionine (SAM) as methyl donors participates in methylation and is converted into S-adenosylhomocysteine (SAH), which is a precursor of homocysteine. Increased plasma SAH and homocysteine are associated with increased risk of cardiovascular disease. However, the relation of plasma SAM with cardiovascular risk is still unclear. Objectives: To determine the relation between plasma SAM and risk of mortality among patients with coronary artery disease (CAD). Methods: Baseline plasma SAM concentrations were measured in 1553 patients with CAD from the Guangdong Coronary Artery Disease Cohort between October 2008 and December 2011. Proportional hazards Cox analyses were performed to ascertain associations between SAM and risk of all-cause and cardiovascular mortality. Results: After a median follow-up of 9.2 (IQR: 8.5-10.2) y, of 1553 participants, 321 had died, including 227 deaths from cardiovascular diseases. Patients in the lowest quartile of SAM concentrations had a higher risk of all-cause death (HR, 1.59; 95% CI: 1.14. 2.21) and cardiovascular death (HR, 2.14; 95% CI: 1.41, 3.27) than those in the highest quartile in multivariable adjusted analysis. Each 1-SD decrease in the SAM concentration remained associated with a 42% greater risk of total death (HR, 1.42: 95% CI: 1.23, 1.64) and a 66% higher risk of cardiovascular death (HR, 1.66: 95% CI: 1.37, 2.01) after fully adjusting for other cardiovascular risk factors. Furthermore, each 1-SD decrease in plasma SAM/SAH ratio, as the methylation index, was also inversely associated with the risk of all-cause (HR, 1.80; 95% CI: 1.42. 2.29) and cardiovascular mortality (HR, 1.68; 95% CI: 1.29, 2.19) in fully adjusted analyses. Conclusions: Our data show a significant inverse relation between plasma SAM and risk of mortality in patients with CAD after adjustment for homocysteine, SAH, and other cardiovascular disease risk factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据